Meet us at euroPLX 2025
In 2025, we will attend the euroPLX 88 Lisbon for Exclusive Partnering Opportunities event taking place in Lisbon, Portugal. This event presents significant opportunities for strategic partnerships, licensing deals, and collaborative projects in the pharmaceutical sector. EuroPLX 88 is known for gathering top executives and decision-makers from around the world to connect, share insights, and unlock new […]
New Distributor: MagnaPharm
We are happy to announce that MagnaPharm and Calmino group AB have teamed up to launch PROIBS® for the treatment of symptoms related to IBS in Romania. “We are proud to announce the partnership of Calmino with MagnaPharm Romania in combined efforts to provide an innovative and certified medical device, PROIBS® for all associated symptoms […]
Meet us @euroPLX
In 2024, we attended the euroPLX 84 Lisbon for Exclusive Partnering Opportunities event taking place in Lisbon, Portugal. This event presented significant opportunities for strategic partnerships, licensing deals, and collaborative projects in the pharmaceutical sector. EuroPLX 84 is renowned for bringing together industry executives from across the globe to explore business opportunities, share insights, and […]
PROIBS® NOW IN FINLAND
We are happy to announce that Calmino Group AB and Aboutmeds (Ranua, Finland) have entered into an exclusive distribution agreement for Finland in order to launch PROIBS® for the treatment of symptoms related to IBS. Aboutmeds was founded in 2017 and operates as an importer and marketer of over-the-counter medicines, nutritional supplements, and healthcare equipment, […]
Meet us @pharmasynergy
The PharmaSynergy conference connects global pharma professionals and showcases pharma opportunities for internationalization, in/out-licensing, investment and portfolio development. Calmino group AB will attend the conference in Berlin, 15-16th September this year. Link to the PharmaSynergy conference PROIBS® is a certified medical device product for the treatment of symptoms related to IBS such as abdominal pain, bloating and changes […]
EWOPHARMA NEW DISTRIBUTOR
We are happy to announce that Calmino group AB and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the territories of the Czech Republic and Slovakia to launch PROIBS® for the treatment of symptoms related to IBS. This agreement includes all marketing and sales activities of PROIBS® as of April 2022. “With […]
Merry Christmas and Happy New Year
Merry Christmas and a Happy New Year from the Calmino Group! What is PROIBS®? PROIBS® is a certified medical device product for the treatment of symptoms related to IBS such as abdominal pain, bloating and changes in bowel movement (diarrhoea and/or constipation). How does PROIBS® work? Watch the video below to see how PROIBS® works. To […]
Pleased to announce our new publication
We have just published a paper in Therapeutic Advances in Gastroenterology “Aloe barbadensis Mill. extract improves symptoms in IBS with diarrhea (IBS-D) in “: A post‑hoc analysis of two randomized double-blind controlled studies” Bani Ghei Ahluwalia and Co-authors Lena Böhn Fredrik Larsson Lena Öhman and Magnus Simrén. Read it here…. Reference details: Ahluwalia B, Magnusson […]
Calmino presenting at Gastrodagarna
We are proud to be presenting our latest research at the Virtual Swedish Gastroenterology Conference, “Svenska Gastrodagarna, 2021”! Don’t miss out our Poster titled “Aloe barbadensis Mill. extract improves symptoms in IBS with diarrhea (IBS-D)” by Bani Ghei Ahluwalia and Co-authors Lena Böhn, Fredrik Larsson, Lena Öhman and Magnus Simrén.
TIME TO CELEBRATE AS PROIBS® turns 10
With PROIBS® turning 10 years old in a time where the world is still facing an unprecedented global health crisis, it is important for us to reflect on the past, and more importantly, to focus on the future. Our growth over the years has been a cumulative outcome of the hard work and non-stop efforts of […]
